LORTAB Drug Patent Profile
✉ Email this page to a colleague
When do Lortab patents expire, and what generic alternatives are available?
Lortab is a drug marketed by Ucb Inc and is included in two NDAs.
The generic ingredient in LORTAB is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.
Summary for LORTAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 16 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LORTAB at DailyMed |
Recent Clinical Trials for LORTAB
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Weill Medical College of Cornell University | Phase 4 |
| The Campbell Foundation | Phase 4 |
| Le Bonheur Children's Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for LORTAB
US Patents and Regulatory Information for LORTAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ucb Inc | LORTAB | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 087722-001 | Jul 9, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Ucb Inc | LORTAB | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 040100-001 | Jan 26, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
